Share：
Share this content in WeChat
X
[Chinese][PDF]879105
• Review •
The latest development of multi-parametric magnetic resonance imaging assisted fusion puncture of prostate
KONG Xiangfeng  CHEN Guojun  BAO Haihua 

Cite this article as: Kong XF, Chen GJ, Bao HH. The latest development of multi-parametric magnetic resonance imaging assisted fusion puncture of prostate. Chin J Magn Reson Imaging, 2019, 10(3): 237-240. DOI:10.12015/issn.1674-8034.2019.03.016.


[Abstract] Currently, the European Urology Association uses multi-parametric magnetic resonance imaging (mp-MRI) as a diagnostic basis for prostate tumors,its diagnostic grade is Ia. And MP-MRI can be combined with other evidence for the diagnosis of prostate tumors.The gold standard for the diagnosis of prostate tumors lies in histopathology, which is particularly important for obtaining pathological diagnosis and is more instructive for the next step of clinical treatment. With the development of biopsy, MRI, fusion puncture and computer technology, the involvement of mp-MRI guided prostate fusion puncture has also gained new development and wider clinical application. This paper reviews recent advances in the diagnosis of prostate tumors, including the application of mp-MRI technology and the aided direct fusion puncture, cognitive fusion targeted biopsy (COG- TB) and software fusion targeted biopsy (FUS-TB).
[Keywords] prostatic neoplasms；punctures；magnetic resonance imaging；ultrasonography

KONG Xiangfeng Urology Surgery, the Affiliation Hospital of Qinghai University, Xi'ning 810001, China

CHEN Guojun* Urology Surgery, the Affiliation Hospital of Qinghai University, Xi'ning 810001, China

BAO Haihua Image Center, the Affiliation Hospital of Qinghai University, Xi'ning 810001, China

*Correspondence to: Chen GJ, E-mail: chenguojun68@126.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of Technology Project of Qinghai Province No. 2017-SF-158
Received  2018-10-15
Accepted  2019-01-20
DOI: 10.12015/issn.1674-8034.2019.03.016
Cite this article as: Kong XF, Chen GJ, Bao HH. The latest development of multi-parametric magnetic resonance imaging assisted fusion puncture of prostate. Chin J Magn Reson Imaging, 2019, 10(3): 237-240. DOI:10.12015/issn.1674-8034.2019.03.016.

[1]
Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol, 2017, 71(4): 618-629.
[2]
柳东辉，王贻兵，李乐义，等. DRE、TRUS与MP-MRI在前列腺癌初筛诊断中的应用价值．中国医药导报, 2016, 13(27): 91-94.
[3]
Wegelin O, van Melick HHE, Hooft L, et al. Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique. Eur Urol, 2017, 71(4): 517-531.
[4]
Sonn GA, Chang E, Natarajan S, et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol, 2014, 65(4): 809-815.
[5]
Robertson NL, Moore CM, Emberton M, et al. Re: magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol, 2012, 187(4): 1511-1512.
[6]
Tyson MD, Arora SS, Scarpato KR, et al. Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer. Urol Oncol, 2016, 34(7): 326-332.
[7]
赵伟，吴永珍，魏利军，等. MRI联合TRUS在前列腺穿刺中的应用价值．检验医学与临床, 2014, 11(18): 2602-2603+2605.
[8]
Winoker JS, Pinto PA, Rastinehad AR, et al. MRI to guide biopsies or avoid biopsies? Curr Opin Urol, 2018, 28(6): 522-528.
[9]
Azadi J, Nguyen ML, Leroy A, et al. The emerging role of imaging in prostate cancer secondary screening: multiparametric magnetic resonance imaging and the incipient incorporation of molecular imaging. Br J Radiol, 2018, 91(1090): 20170960.
[10]
Goldman H, Singh N, Harding C, et al. Accuracy of multiparametric magnetic resonance imaging to detect significant prostate cancer and index lesion location. ANZ J Surg, 2018. DOI:
[11]
Lee DJ, Recabal P, Sjoberg DD, et al. Comparative effectiveness of targeted prostate biopsy using magnetic resonance imaging ultrasound fusion software and visual targeting: a prospective study. J Urol, 2016, 196(3): 697-702.
[12]
Moore CM, Robertson NL, Arsanious N, et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol, 2013, 63(1): 125-140.
[13]
Natarajan S, Marks LS, Margolis DJ, et al. Clinical application of a 3D ultrasound-guided prostate biopsy system. Urol Oncol, 2011, 29(3): 334-342.
[14]
Brown LC, Ahmed HU, Faria R, et al. Multiparametric MRI to improve detection of prostate cancer compared withtransrectal ultrasound-guided prostate biopsy alone: the PROMIS study. Health Technol Assess, 2018, 22(39): 1-176.
[15]
胡林军，寿建忠，邢念增，等．经会阴认知融合MRI前列腺靶向穿刺71例单中心临床研究．中国临床医生杂志, 2018, 46(08): 935-938.
[16]
Tyson MD, Arora SS, Scarpato KR, et al. Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer. Urol Oncol, 2016, 34(7): 326-332.
[17]
Sonn GA, Chang E, Natarajan S, et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol, 2014, 65(4): 809-815.
[18]
Oberlin DT, Casalino DD, Frank H, et al. Diagnostic value of guided biopsies: fusion and cognitive-registration magnetic resonance imaging versus conventional ultrasound biopsy of the prostate. Urology, 2016, 92(12): 75-79.
[19]
Liss MA, Kim W, Moskowitz D, et al. Comparative effectiveness of targeted vs empirical antibiotic Prophylaxis to prevent sepsis from transrectal prostate biopsy: a retrospective analysis. J Urol, 2015, 194(2): 224-225.
[20]
Cornud F, Roumiguié M, de Longchamps NB, et al. Precision matter in MR imaginy-targeted prostate biopsy: evidence from a prostate study of cognitive and elastic fusion registration transrectal biopsy. Radiology, 2018, 41(4): 472-473.
[21]
Kim EH, Johnson MH, Andriole GL, et al. Re: A Prospective, Blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of mr-targeted prostate biopsy: the PROFUS trial. Eur Urol, 2014, 66(3): 595-595.
[22]
Kaufmann S, Russo GI, Bamberg F, et al. Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI target biopsy. World J Urol, 2018, 36(5): 761-768.
[23]
Taneja SS. Re: Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy: prospective multicenter study. J Urol, 2013, 190(5): 1765-1765.
[24]
Kaufmann S, Russo GI, Thaiss W, et al. Cognitive versus software-assisted registration: development of a new nomogram predicting prostate cancer at MRI-targeted biopsies. Clin Genitourin Cancer, 2018, 16(4): e953-e960.
[25]
Borkowetz A, Platzek I, Toma M, et al. Evaluation of prostate imaging reporting and data system classification in the prediction of tumor aggressiveness in targeted magnetic resonance imaging/ultrasound-fusion biopsy. Urol Int, 2017, 99(2): 177-185.
[26]
Monda SM, Vetter JM, Andriole GL, et al. Cognitive versus software fusion for MRI-targeted biopsy: experience before and after implementation of fusion. Urology, 2018, 119(9): 115-120.
[27]
Mertan FV, Greer MD, Shih JH, et al. Prospective evaluation of the prostate imaging reporting and data system version 2 for prostate cancer detection. The Journal of Urology, 2016, 196(3): 690-696.
[28]
DOI: Sungmin Woo, Chong Hyun Suh, Sang Youn Kim, Jeong Yeon Cho, Seung Hyup Kim. Diagnostic performance of prostate imaging reporting and data system version 2 for detection of prostate cancer: a systematic review and diagnostic Meta-analysis. Eur Urol, 2017, 72:177-88. Eur Urol, 2018, 73(2): e30.
[29]
Zhang L, Tang M, Lei X, et al. A Meta-analysis of use of prostate imaging reporting and data system version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer. Eur Radiol, 2017, 27(12): 5204-5214.
[30]
王燕，高旭，阳青松，等. 3D打印技术辅助认知融合在前列腺穿刺活检术中的应用．临床泌尿外科杂志, 2016, 31(02): 104-107.
[31]
Womble PR, Linsell SM, Gao Y, et al. A statewide intervention to reduce hospitalizations after prostate biopsy. J Urol, 2015, 194(2): 403-409.

PREV Advances in imaging research of diabetes-related sarcopenia
NEXT Modulation of catechol-O-methyltransferase Val158Met polymorphism on topological reorganization of white-matter networks in attention-deficit/hyperactivity disorder children
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn